Nutrition and immune function in human immunodeficiency virus infection

被引:20
作者
Macallan, DC [1 ]
机构
[1] Univ London St Georges Hosp, Sch Med, Div Infect Dis, London SW17 0RE, England
关键词
HIV infection; AIDS; nutritional status; wasting; micronutrients;
D O I
10.1017/S002966519900097X
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The tried of human immunodeficiency virus (HIV) infection, nutritional status and immune function are intimately related, each factor having effects on the others. The dominant effect in this three-way relationship is the effect of HIV infection on nutritional status, an effect which, until the advent of potent anti-retroviral drugs, has been manifest primarily as wasting. Recently, more complex metabolic abnormalities have become apparent, particularly fat redistribution syndromes, hyperlipidaemia and hypercholesterolaemia. For the converse effect, the effect of nutritional state on HIV disease progression, there is good evidence that clinical outcome is poorer in individuals with compromised nutrition. However, the beneficial effects of nutritional support have been more difficult to demonstrate. For macronutrients, effective macronutrient supply improves survival in severely-malnourished individuals and may have beneficial effects in less-severely-affected individuals. Micronutrient deficiencies appear to be involved in modifying clinical HIV disease and may also be associated with enhanced mother-to-child transmission of virus, particularly in developing countries. Intervention trials in this setting are currently under way. In conclusion, the interaction of HIV infection and nutrition is of great importance not just because of the major impact that HIV infection has on nutritional state, but also because strategies to improve nutritional status, both quantitatively and qualitatively, may have a beneficial effect on the clinical and immunological course of the disease.
引用
收藏
页码:743 / 748
页数:6
相关论文
共 38 条
[1]  
[Anonymous], MMWR
[2]   MICRONUTRIENTS AND HIV-1 DISEASE PROGRESSION [J].
BAUM, MK ;
SHORPOSNER, G ;
LU, Y ;
ROSNER, B ;
SAUBERLICH, HE ;
FLETCHER, MA ;
SZAPOCZNIK, J ;
EISDORFER, C ;
BURING, JE ;
HENNEKENS, CH .
AIDS, 1995, 9 (09) :1051-1056
[3]  
Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0
[4]   Effect of indinavir on HIV-related wasting [J].
Carbonnel, F ;
Maslo, C ;
Beaugerie, L ;
Carratt, F ;
Wirbel, E ;
Aussel, C ;
Gobert, JG ;
Girard, PM ;
Gendre, JP ;
Cosnes, J ;
Rozenbaum, W .
AIDS, 1998, 12 (14) :1777-1784
[5]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[6]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883
[7]  
Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S
[8]   1990 MCCOLLUM AWARD LECTURE - NUTRITION AND IMMUNITY - LESSONS FROM THE PAST AND NEW INSIGHTS INTO THE FUTURE [J].
CHANDRA, RK .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (05) :1087-1101
[9]   Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania [J].
Fawzi, WW ;
Msamanga, GI ;
Spiegelman, D ;
Urassa, EJN ;
McGrath, N ;
Mwakagile, D ;
Antelman, G ;
Mbise, R ;
Herrera, G ;
Kapiga, S ;
Willett, W ;
Hunter, DJ .
LANCET, 1998, 351 (9114) :1477-1482
[10]  
FORCE G, 1997, NUTRITION, V13, P290